http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2382041-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a101999f5758133cc0dfd48862b09f6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93e7d6590381522f203950d8e0e41888
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbed065fc05773021cc2b098db8209d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb6af4c06b8e51d7d66645e891cbe04b
publicationDate 2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2382041-T3
titleOfInvention Alpha and beta emission hydroxyapatite particles
abstract Use of hydroxyapatite (HA) and an alpha emission radionuclide chosen from the group of 211At, 212Bi, 223Ra, 224Ra, 225Ac, 227Th or a beta emission radionuclide chosen from the group of 212Pb, 211Pb, 213Bi or 225Ra in the manufacture of a medicine for use in the treatment of a cancerous disease
priorityDate 2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449029786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415730065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335500
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335491
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577481
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5355457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453253805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454118689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23926

Total number of triples: 56.